Previous 10 | Next 10 |
2023-11-21 09:53:36 ET A dividend yield can tell you a lot about a payout. Not only does it tell you how much you could be collecting in dividend income, but it can give you an indication of investor sentiment, and whether the stock struggles or is doing well. An excessively high yield, for...
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Piper Sandler 35 th Annual Healthcare Conference ...
2023-11-08 05:28:37 ET More on Organon Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace Organon & Co (OGN) Q3 2023 Earnings Call Transcript Organon: The Federal Reserve Black Swan (Rating Upgrade) Goldman downgrades Organon following...
sBLA based on Phase 4 study which assessed pharmacokinetic similarity between two treatment groups: multi-switching group alternating between Humira and high-concentration HADLIMA vs. Humira-continued group Filing acceptance reinforces Samsung Bioepis and Organon’s commitment to pr...
2023-11-07 13:04:38 ET Summary Organon & Co. reported its Q3 earnings, last week, which revealed underperformance in its Women's Health division and struggles in its biosimilars division. The company's debt position remains high, with net debt standing at over $8 billion. ...
2023-11-03 10:42:01 ET Organon & Co ( NYSE: OGN ) has been downgraded by Goldman Sachs from Buy to Neutral after the Merck spinoff fell short of both top and bottom line expectations in its latest Q3 report . Revenue in women's health, Organon's biggest unit, fell 8% Y/Y...
2023-11-03 00:55:40 ET Summary SPDR S&P 600 Small Cap Value ETF is invested in over 400 small caps with a tilt to value over growth. It is well-diversified across sectors and holdings. The sector breakdown, valuation ratios and historical performance are not much different...
2023-11-02 13:29:17 ET Shares of Organon ( NYSE: OGN ) on Thursday slumped as much as 12.5% to a record low of $12.83, after the company saw a quarterly revenue decline in its main women's health business. Pharmaceutical giant Merck ( MRK ) spun-off Organon ( OGN ) i...
2023-11-02 12:21:05 ET Organon & Co (OGN) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Matthew Walsh - CFO Sandra Milligan - Head of R&D Conference Call Participants ...
2023-11-02 09:00:00 ET Summary Pfizer's stock has dropped due to a decline in revenues post-COVID, presenting a value investment opportunity. The company still generates significant gross profit and has a strong revenue growth rate. Pfizer's low Price-to-Earnings ratio and imp...
News, Short Squeeze, Breakout and More Instantly...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an investigational Prolia ® and Xgeva ® (denosumab) biosimilar. Denosumab has been a...
2024-05-23 02:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...